Brain Neurorehabil.  2015 Sep;8(2):59-64. 10.12786/bn.2015.8.2.59.

Diagnosis and Treatment of Post-Stroke Delirium

• Kim NY
• Kim YW

• KMID: 2165191
• DOI: http://doi.org/10.12786/bn.2015.8.2.59

Abstract

Delirium is an acute disturbance of consciousness and cognition with fluctuating course over a short period of time. Recognition of delirium in post-stroke patients is important because of its association with a longer stay in the hospital, a poor functional outcome, an increased risk of deteriorated cognition, and a higher mortality rate. It is occasionally under-recognized due to the fluctuating course and the neurological deficits that are caused by the stroke. Disturbance of several neurotransmitter systems including not only acetylcholine and dopamine but also serotonin, noradrenaline and gamma amino butyric acid have been implicated for the possible pathophysiology of delirium. Numerous potential precipitating and predisposing factors have been proposed such as comorbid condition, age, acute medical insults and environmental issues. In view of the complex multifactorial causes of delirium, multicomponent non-pharmacological approaches for risk factors are the most effective strategy for prevention of delirium. Preventive interventions such as frequent reorientation, early and recurrent mobilization, pain management, adequate nutrition and hydration, reducing sensory impairments, and ensuring proper sleep patterns have all been shown to reduce the incidence of delirium, regardless of the care environment. Pharmacologic interventions and physical restraints should be reserved for patients who are a threat to their own safety or the safety of others. This review describes epidemiology, pathophysiology, risk factors, diagnostic methods, and management of delirium in post-stroke patients.

Keyword

delirium; stroke; treatment

MeSH Terms

Acetylcholine
Butyric Acid
Causality
Cognition
Consciousness
Delirium*
Diagnosis*
Dopamine
Epidemiology
Humans
Incidence
Mortality
Neurotransmitter Agents
Norepinephrine
Pain Management
Restraint, Physical
Risk Factors
Serotonin
Stroke
Acetylcholine
Butyric Acid
Dopamine
Neurotransmitter Agents
Norepinephrine
Serotonin

Reference

1. Gustafson Y, Olsson T, Eriksson S, Asplund K, Bucht G. Acute confusional states (delirium) in stroke patients. Cerebrovasc Dis. 1991; 1:257–264.

2. Langhorne P, Stott D, Robertson L, MacDonald J, Jones L, McAlpine C, Dick F, Taylor G, Murray G. Medical complications after stroke a multicenter study. Stroke. 2000; 31:1223–1229.

3. McManus J, Pathansali R, Stewart R, Macdonald A, Jackson S. Delirium post-stroke. Age Ageing. 2007; 36:613–618.

4. Caeiro L, Ferro JM, Albuquerque R, Figueira ML. Delirium in the first days of acute stroke. J Neurol. 2004; 251:171–178.

5. Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006; 35:350–364.

6. McManus J, Pathansali R, Hassan H, Ouldred E, Cooper D, Stewart R, Macdonald A, Jackson S. The course of delirium in acute stroke. Age Ageing. 2009; 38:385–389.

7. van Rijsbergen MW, Oldenbeuving AW, Nieuwenhuis-Mark RE, Nys GM, Las SG, Roks G, de Kort PL. Delirium in acute stroke: a predictor of subsequent cognitive impairment? A two-year follow-up study. J Neurol Sci. 2011; 306:138–114.

8. Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM Jr. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999; 340:669–667.

9. Clegg A, Siddiqi N, Heaven A, Young J, Holt R. Interventions for preventing delirium in older people in institutional long-term care. Cochrane Database Syst Rev. 2014; 1:Cd009537.

10. Maldonado JR. Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment. Crit Care Clin. 2008; 24:789–856, ix.

11. Trzepacz PT. Anticholinergic Model For Delirium. Semin Clin Neuropsychiatry. 1996; 1:294–303.

12. White S. The neuropathogenesis of delirium. Rev Clin Gerontol. 2002; 12:62–67.

13. Karlsson I. Drugs that induce delirium. Dement Geriatr Cogn Disord. 1999; 10:412–415.

14. Han L, McCusker J, Cole M, Abrahamowicz M, Primeau F, Elie M. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001; 161:1099–1105.

15. Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry. 2000; 5:132–148.

16. Platt MM, Breitbart W, Smith M, Marotta R, Weisman H, Jacobsen PB. Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci. 1994; 6:66–67.

17. Olsson T. Activity in the hypothalamic-pituitary-adrenal axis and delirium. Dement Geriatr Cogn Disord. 1999; 10:345–349.

18. Hshieh TT, Fong TG, Marcantonio ER, Inouye SK. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci. 2008; 63:764–772.

19. de Rooij SE, van Munster BC, Korevaar JC, Levi M. Cytokines and acute phase response in delirium. J Psychosom Res. 2007; 62:521–525.

20. Adamis D, Lunn M, Martin FC, Treloar A, Gregson N, Hamilton G, Macdonald AJ. Cytokines and IGF-I in delirious and non-delirious acutely ill older medical inpatients. Age Ageing. 2009; 38:326–332.

21. Blass JP, Gibson GE. Cerebrometabolic aspects of delirium in relationship to dementia. Dement Geriatr Cogn Disord. 1999; 10:335–338.

22. Fong TG, Bogardus ST, Daftary A, Auerbach E, Blumenfeld H, Modur S, Leo-Summers L, Seibyl J, Inouye SK. Cerebral perfusion changes in older delirious patients using 99mTc HMPAO SPECT. J Gerontol A Biol Sci Med Sci. 2006; 61:1294–1299.

23. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014; 383:911–922.

24. Henon H, Lebert F, Durieu I, Godefroy O, Lucas C, Pasquier F, Leys D. Confusional state in stroke relation to preexisting dementia, patient characteristics, and outcome. Stroke. 1999; 30:773–779.

25. Dunne J, Leedman P, Edis R. Inobvious stroke: a cause of delirium and dementia. Aust N Z J Med. 1986; 16:771–778.

26. Mesulam MM. Large scale neurocognitive networks and distributed processing for attention. Ann Neurol. 1990; 28:597–613.

27. Vatsavayi V, Malhotra S, Franco K. Agitated delirium with posterior cerebral artery infarction. J Emerg Med. 2003; 24:263–266.

28. Verslegers W, De Deyn P, Saerens J, Marien P, Appel B, Pickut B, Lowenthal A. Slow progressive bilateral posterior artery infarction presenting as agitated delirium, complicated with Anton's syndrome. Eur Neurol. 1991; 31:216–219.

29. Sheng AZ, Shen Q, Cordato D, Zhang YY, Chan Y, Kam D. Delirium within three days of stroke in a cohort of elderly patients. J Am Geriatr Soc. 2006; 54:1192–1198.

30. Bogousslavsky J, Ferrazzini M, Regli F, Assal G, Tanabe H, Delaloye-Bischof A. Manic delirium and frontal-like syndrome with paramedian infarction of the right thalamus. J Neurol Neurosurg Psychiatry. 1988; 51:116–119.

31. Boiten J, Lodder J. [An unusual sequela of a frequently occurring neurologic disorder: delirium caused by brain infarct]. Ned Tijdschr Geneeskd. 1989; 133:617–620.

32. Sandberg O, Franklin KA, Bucht G, Gustafson Y. Sleep apnea, delirium, depressed mood, cognition, and ADL ability after stroke. J Am Geriatr Soc. 2001; 49:391–397.

33. Inouye SK. The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med. 1994; 97:278–288.

34. Carin-Levy G, Mead GE, Nicol K, Rush R, van Wijck F. Delirium in acute stroke: screening tools, incidence rates and predictors: a systematic review. J Neurol. 2012; 259:1590–1599.

35. Inouye SK, Van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method: a new method for detection of delirium. Ann Intern Med. 1990; 113:941–948.

36. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res. 1988; 23:89–97.

37. Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci. 2001; 13:229–242.

38. Flaherty JH. The evaluation and management of delirium among older persons. Med Clin North Am. 2011; 95:555–577, xi.

39. Marchington KL, Carrier L, Lawlor PG. Delirium masquerading as depression. Palliat Support Care. 2012; 10:59–62.

40. Nicholas LM, Lindsey BA. Delirium presenting with symptoms of depression. Psychosomatics. 1995; 36:471–479.

41. Inouye SK. Delirium in older persons. N Engl J Med. 2006; 354:1157–1165.

42. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationship with baseline vulnerability. JAMA. 1996; 275:852–857.

43. Powell C, Mitchell-Pedersen L, Fingerote E, Edmund L. Freedom from restraint: consequences of reducing physical restraints in the management of the elderly. CMAJ. 1989; 141:561.

44. Mion LC, Fogel J, Sandhu S, Palmer RM, Minnick AF, Cranston T, Bethoux F, Merkel C, Berkman CS, Leipzig R. Outcomes following physical restraint reduction programs in two acute care hospitals. Jt Comm J Qual Improv. 2001; 27:605–618.

45. Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for delirium. Cochrane Database Syst Rev. 2007; Cd005594.

46. Oldenbeuving A, De Kort P, Jansen B, Roks G, Kappelle L. Delirium in acute stroke: a review. Int J Stroke. 2007; 2:270–275.